Drug Development Pipeline Probability-of-Success Evaluator

Estimates an asset's probability of technical and regulatory success (PTRS) by combining published phase-transition benchmarks with asset-specific risk adjustments across mechanism, target validation, clinical data quality, regulatory path, and competitive context — then outputs a structured confidence score, stage-by-stage cumulative LOA, and the top risk drivers and de-risking actions. Use when evaluating a pipeline asset's likelihood of approval, comparing portfolio candidates, building risk-adjusted forecasts, or diligencing an in-licensing or acquisition target.